 Biofrontera Inc NASDAQ: BFRI shares are trading significantly higher Wednesday after the company announced it received U.S. Food and Drug Administration approval for its cGMP laboratory in Germany. The FDA has approved Biofronteras German laboratory as a contract lab for batch. 